ALDERAAN BIOTECHNOLOGY is a biotechnology company based in France. It aims at developing novel therapies to treat cancer by targeting cells from the immune system. Its programs are related to the elimination of Regulatory T cells as well as to the hyper activation of Natural Killer cells in the tumor microenvironment.
Between €10 million-€25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Alderaan Biotechnology? We’re happy to assist you with our Startup Sourcing service.